Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT.
Publication
, Journal Article
Shah, NP; McGuire, DK; Cannon, CP; Giugliano, RP; Lokhnygina, Y; Page, CB; Tershakovec, AM; Braunwald, E; Blazing, MA
Published in: J Am Heart Assoc
July 4, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
July 4, 2023
Volume
12
Issue
13
Start / End Page
e029593
Location
England
Related Subject Headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Ezetimibe
- Drug Therapy, Combination
- Diabetes Mellitus
- Anticholesteremic Agents
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, N. P., McGuire, D. K., Cannon, C. P., Giugliano, R. P., Lokhnygina, Y., Page, C. B., … Blazing, M. A. (2023). Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT. J Am Heart Assoc, 12(13), e029593. https://doi.org/10.1161/JAHA.122.029593
Shah, Nishant P., Darren K. McGuire, Christopher P. Cannon, Robert P. Giugliano, Yuliya Lokhnygina, Courtney B. Page, Andrew M. Tershakovec, Eugene Braunwald, and Michael A. Blazing. “Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT.” J Am Heart Assoc 12, no. 13 (July 4, 2023): e029593. https://doi.org/10.1161/JAHA.122.029593.
Shah NP, McGuire DK, Cannon CP, Giugliano RP, Lokhnygina Y, Page CB, et al. Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT. J Am Heart Assoc. 2023 Jul 4;12(13):e029593.
Shah, Nishant P., et al. “Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT.” J Am Heart Assoc, vol. 12, no. 13, July 2023, p. e029593. Pubmed, doi:10.1161/JAHA.122.029593.
Shah NP, McGuire DK, Cannon CP, Giugliano RP, Lokhnygina Y, Page CB, Tershakovec AM, Braunwald E, Blazing MA. Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT. J Am Heart Assoc. 2023 Jul 4;12(13):e029593.
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
July 4, 2023
Volume
12
Issue
13
Start / End Page
e029593
Location
England
Related Subject Headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Ezetimibe
- Drug Therapy, Combination
- Diabetes Mellitus
- Anticholesteremic Agents
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology